H-1B sponsorship profile: American Oncologic Hospital D/B/A Fox Chase Cancer Center. Across U.S. Department of Labor LCA disclosures, American Oncologic Hospital D/B/A Fox Chase Cancer Center filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on American Oncologic Hospital D/B/A Fox Chase Cancer Center’s H-1B petitions range from $70,658 at the low end to $70,658 at the high end, with a petition-weighted average of $70,658. That range reflects the mix of occupations the company sponsors, led by Process Improvement Coordinator (2 petitions at $70,658 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. American Oncologic Hospital D/B/A Fox Chase Cancer Center is headquartered in Philadelphia, PA under NAICS code 54171, and places H-1B workers across 1 state, most heavily in PA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where American Oncologic Hospital D/B/A Fox Chase Cancer Center ranks. By H-1B petition volume, American Oncologic Hospital D/B/A Fox Chase Cancer Center is #48,558 of 119,880 employers nationally and #1,408 of 3,282 employers headquartered in PA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.